Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

36.67
Delayed Data
As of Feb 05
 -0.61 / -1.64%
Today’s Change
25.50
Today|||52-Week Range
43.63
-14.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues117.9M99.9M113.7M148.2M
 
 
 
 
 
Cost of Goods Sold22.0M14.9M19.1M21.2M
 
 
 
 
 
Depreciation And Amortization3.1M3.7M3.8M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income92.7M81.2M90.8M123.3M
 
 
 
 
 
General Expenses77.8M79.4M84.0M94.4M
 
 
 
 
 
Research And Development25.9M30.6M31.2M43.4M
 
 
 
 
 
Total Operating Expenses103.0M98.0M106.9M119.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income14.9M1.8M6.8M28.9M
 
 
 
 
 
Extraordinary Credit263.0K----0.00
 
 
Extraordinary Charge-14.0M-3.1M-1.1M-3.2M
 
 
 
 
 
Interest Expense On Debt4.2M4.1M4.0M4.0M
 
 
 
 
 
Other Expenses0.00121.0K351.0K-59.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.7M-5.1M2.1M21.7M
 
 
 
 
 
Income Taxes-3.0M-2.0M-1.1M-17.8M
 
 
 
 
 
Net Income330.0K-3.1M997.0K3.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.5M42.0M42.1M42.2M
 
 
 
 
 
Shares To Calculate EPS Diluted43.1M42.0M43.3M43.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.01-$0.07$0.02$0.09
 
 
 
 
 
EPS Diluted$0.01-$0.07$0.02$0.09